|
|
|
|
|
The early diagnostic value of miR-20a-5p on acute kidney injury in patients with sepsis |
Li Da-yong, Dai Yao, Liu Guan-lan, Guo Ning, Tong Guo-xiang |
Department of Critical Care Medicine, First Hospital of Changsha, Changsha 410005, China |
|
|
Abstract Objective To screen peripheral blood miRNAs related with acute kidney injury (AKI) in patients with sepsis; and to investigate the early diagnostic value of miRNAs on sepsis-AKI. Methods 82 patients with sepsis in our hospital were selected from September 2016 to January 2018 and divided into patients with sepsis combined with AKI (sepsis-AKI group, n=43) and patients without AKI group (sepsis group, n=39).Serum miRNA expression profiles were determined in blood samples from sepsis patients (after admission of 3 d) and sepsis-AKI patients (on diagnosis day or before 1 d). The levels of plasma miRNAs, biochemistry indexes, APACHEⅡ scores and qSOFA scores were detected and compared between the two groups. Results ①There was statistical difference of the baseline values of liver and kidney function indexes, APACHEⅡ scores and qSOFA scores between sepsis group (after admission of 3 d) and sepsis-AKI group(on diagnosis day) (P<0.05). ②The glomerlar filtration rate (GFR) of sepsis-AKI patients before diagnosis of 1 d were lower than sepsis patients without AKI (after admission of 3d) (P<0.05). ③The serum miR-20a-5p expression levelsin peripheral blood of sepsis-AKI patients before diagnosis of 1d were higher than sepsis patients without AKI (after admission of 3 d) (P<0.05). ④The high miR-20a-5p expression was an independent risk factor of AKI in sepsis patients (P<0.05). ⑤The AUC of ROC curve of miR-20a-5p was 0.923. Conclusion It suggested that miR-20a-5p is a sensitive predictor of acute kidney injury in patients with sepsis.
|
|
About author:: Li Da-yong, E-mail: xie258036@163.com |
|
|
|
[1]徐大民, 杨莉. 脓毒症相关急性肾损伤[J]. 中国实用内科杂志, 2016, 36 (6): 441-444.
[2]王瑶, 王洪亮. 急性肾损伤相关生物标志物研究现状[J]. 中国急救医学, 2018, 38(2): 108–110.
[3]朱桂军, 胡振杰. 急性肾损伤定义及诊断标准的昨天、今天与明天[J]. 中国急救医学, 2018, 38(2): 114–117.
[4]Zhou J, Chen H, Fan Y. Systematic analysis of the expression profile of non-coding RNAs involved in ischemia/reperfusion-induced acute kidney injury in mice using RNA sequencing [J]. Oncotarget, 2017, 8(59):100196-100215.
[5]中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014)[J]. 中华内科杂志, 2015, 54(6):557-581.
[6]Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J]. Am J Kidney Dis, 2013, 61(5): 649-672.
[7]Karthikeyan B, Sharma RK. Management of acute kidney injury in sepsis[J]. Clinical Queries Nephrology, 2016, 5(1): 16-20.
[8]Chung KK, Stewart IJ, Gisler C, et al. The Acute Kidney Injury Network (AKIN) criteria applied in burns[J]. J Burn Care Res, 2012, 33(4):483-490.
[9]Skube SJ, Katz SA, Chipman JG, et al. Acute Kidney injury and Sepsis[J]. Surg Infect (Larchmt), 2018, 19(2):216-224.
[10]Rodríguez E, Arias-Cabrales C, Bermejo S, et al. Impact of Recurrent Acute Kidney injury on Patient Outcomes[J]. Kidney Blood Press Res, 2018, 43(1):34-44.
[11]Hellou E, Bahouth Z, Sabo E, et al. The impact of comorbidities, sex and age on the occurrence of acute kidney injury among patients undergoing nephron-sparing surgery[J]. Ther Adv Urol, 2018, 10(3):103-108.
[12]Mohamed MA, Hamid KA. How an Elevated Creatinine Level Can Deter the Diagnosis of Acute Aortic Dissection[J]. Cureus, 2018, 10(1):e2057.
[13]罗旭颖, 周建新, 席修明. 急性肾损伤的诊断:肌酐还是尿量[J]. 中华重症医学电子杂志, 2017, 32(1):9-13.
[14]王寅, 王蓓莉, 郭玮, 等. 肾小球滤过率计算公式的发展和比较[J]. 检验医学, 2015, 30(7): 668-673.
[15]Bjornstad P, Karger AB, Maahs DM. Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots[J]. Adv Chronic Kidney Dis, 2018, 25(1):76-83.
[16]Wang Q, Ma J, Jiang Z, et al. Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: A systematic review and meta- analysis[J]. Medicine (Baltimore), 2017, 96(24): e7173.
[17]Xu T, Wu J, Han P, et al. Circular RNA expression profiles and features in human tissues: a study using RNA-seq data[J]. BMC Genomics, 2017, 18(Suppl 6):680.
[18]王勤熙, 姚见儿, 顾国浩. microRNAs的定量分析技术及其应用[J]. 临床检验杂志, 2012, 30(9):650-652.
[19]Ichii O, Horino T. MicroRNAs associated with the development of kidney diseases in humans and animals[J]. J Toxicol Pathol, 2018, 31(1):23-34. |
|
|
|